XML 26 R14.htm IDEA: XBRL DOCUMENT
v3.20.4

Note 7 - Intangible Assets - Amortizable | 6 Months Ended
--- | ---
Dec. 31, 2020
Notes to Financial Statements |
Intangible Assets Disclosure [Text Block] | 7. Intangible Assets – Amortizable The Company currently holds the following intangible asset portfolios as of December 31, 2020 : (i) Licensed assets, which consist of pharmaceutical product assets that were acquired prior to July 1, 2020; ( ii) Product technology rights, acquired from the November 1, 2019 acquisition of the Pediatric Portfolio from Cerecor; and, as a result of the Merger with Innovus on February 14, 2020, both, (iii) the Acquired product distribution rights; consisting of patents and trade names, and the Acquired customer lists. If acquired in an asset acquisition, the Company capitalized the acquisition cost of each licensed patent or tradename, which can include a combination of both upfront consideration, as well as the estimated future contingent consideration estimated at the acquisition date. If acquired in a business combination, the Company capitalizes the estimated fair value of the intangible asset or assets acquired, based primarily on a discounted cash flow model approach or relief-from-royalties model. The following table provides the summary of the Company's intangible assets as of December 31, 2020 and June 30, 2020 , respectively.
|  | December 31, 2020 |
|  | Gross Carrying Amount |  |  | Accumulated Amortization |  |  | Impairment |  |  | Net Carrying Amount |  |  | Weighted-Average Remaining Life (in years) |
Licensed assets |  | $ | 23,649,000 |  |  | $ | (8,200,000 | ) |  | $ | - |  |  | $ | 15,449,000 |  |  |  | 11.72 |
Acquired product technology right |  |  | 22,700,000 |  |  |  | (2,648,000 | ) |  |  | - |  |  |  | 20,052,000 |  |  |  | 8.84 |
Acquired product distribution rights |  |  | 11,354,000 |  |  |  | (1,319,000 | ) |  |  | - |  |  |  | 10,035,000 |  |  |  | 7.27 |
Acquired customer lists |  |  | 390,000 |  |  |  | (227,000 | ) |  |  | - |  |  |  | 163,000 |  |  |  | 0.62 |
|  | $ | 58,093,000 |  |  | $ | (12,394,000 | ) |  | $ | - |  |  | $ | 45,699,000 |  |  |  | 9.44 |
|  | June 30, 2020 |
|  | Gross Carrying Amount |  |  | Accumulated Amortization |  |  | Impairment |  |  | Net Carrying Amount |  |  | Weighted-Average Remaining Life (in years) |
Licensed assets |  | $ | 23,649,000 |  |  | $ | (7,062,000 | ) |  | $ | - |  |  | $ | 16,587,000 |  |  |  | 11.88 |
MiOXSYS Patent |  |  | 380,000 |  |  |  | (185,000 | ) |  |  | (195,000 | ) |  |  | - |  |  |  | - |
Acquired product technology right |  |  | 22,700,000 |  |  |  | (1,513,000 | ) |  |  | - |  |  |  | 21,187,000 |  |  |  | 9.34 |
Acquired product distribution rights |  |  | 11,354,000 |  |  |  | (565,000 | ) |  |  | - |  |  |  | 10,789,000 |  |  |  | 7.78 |
Acquired customer lists |  |  | 390,000 |  |  |  | (98,000 | ) |  |  | - |  |  |  | 292,000 |  |  |  | 1.12 |
|  | $ | 58,473,000 |  |  | $ | (9,423,000 | ) |  | $ | (195,000 | ) |  | $ | 48,855,000 |  |  |  | 9.11 |
The following table summarizes the estimated future amortization expense to be recognized over the next five years and periods thereafter:
|  | Amortization |
2021 |  | $ | 3,157,000 |
2022 |  |  | 6,085,000 |
2023 |  |  | 6,045,000 |
2024 |  |  | 6,033,000 |
2025 |  |  | 4,480,000 |
Thereafter |  |  | 19,899,000 |
|  | $ | 45,699,000 |
Certain of the Company's amortizable intangible assets include renewal options, extending the expected life of the asset. The renewal periods range between approximately 1 to 20 years depending on the license, patent, or other agreement. Renewals are accounted for when they are reasonably assured. Intangible assets are amortized using the straight-line method over the estimated useful lives. Amortization expense of intangible assets was $1.6 million and $0.9 million for the three months ended December 31, 2020 and 2019 , respectively. Amortization expense of intangible assets was $3.2 million and $1.5 million for the six months ended December 31, 2020 and 2019 , respectively.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for all or part of the information related to intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -URI http://asc.fasb.org/topic&trid=2144416 + Details
Name: | us-gaap_IntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration